530057
VIVANZA
Start SIP
Invest Now
Start SIP in VIVANZA
Performance
- Low
- ₹2
- High
- ₹2
- 52 Week Low
- ₹2
- 52 Week High
- ₹3
- Open Price₹2
- Previous Close₹2
- Volume57,258
- 50 DMA₹2.12
- 100 DMA₹2.14
- 200 DMA₹2.35
Investment Returns
- Over 1 Month -4.02%
- Over 3 Month -9.66%
- Over 6 Month + 4.88%
- Over 1 Year -7.33%
Smart Investing Starts Here Start SIP with Vivanza Biosciences for Steady Growth!
Vivanza Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -56.2
- PEG Ratio
- 0.8
- Market Cap Cr
- 9
- P/B Ratio
- 1.9
- Average True Range
- 0.07
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.02
- RSI
- 53.19
- MFI
- 60.74
Vivanza Biosciences Financials
Vivanza Biosciences Technicals
EMA & SMA
Current Price
₹2.15
+
0.1
(4.88%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹2.10
- 50 Day
- ₹2.12
- 100 Day
- ₹2.14
- 200 Day
- ₹2.35
Resistance and Support
2.12
- R3 2.26
- R2 2.20
- R1 2.18
- S1 2.10
- S2 2.04
- S3 2.02
Vivanza Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-12 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-09-01 | Others | Inter-alia, to consider 1. Appoint Mr. Chintan K. Patel, Practicing Company Secretary as a Scrutinizer & Secretarial Auditors of the Company. 2. Draft notice of 43rd AGM. 3. Other business matters. split from Rs. 10/- to Re. 1/-. |
| 2025-08-13 | Quarterly Results | |
| 2025-05-12 | Audited Results |
Vivanza Biosciences F&O
About Vivanza Biosciences
- NSE Symbol
- VIVANZA
- BSE Symbol
- 530057
- Managing Director
- Mr. J A Mehta
- ISIN
- INE984E01035
Similar Stocks to Vivanza Biosciences
Vivanza Biosciences FAQs
Vivanza Biosciences share price is ₹2 As on 14 February, 2026 | 09:18
The Market Cap of Vivanza Biosciences is ₹8.6 Cr As on 14 February, 2026 | 09:18
The P/E ratio of Vivanza Biosciences is -56.2 As on 14 February, 2026 | 09:18
The PB ratio of Vivanza Biosciences is 1.9 As on 14 February, 2026 | 09:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.